Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.49 |
| ▸ | KCNH3 | Q9ULD8 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30269680 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TDP1L3MBTL1LMNACYP3A4 | |
| SCHEMBL7688439 | 0.86 | TUBB4A (0.51) | ALDH1A1TDP1L3MBTL1LMNACYP3A4 | |
| SCHEMBL14243738 | 0.83 | KDR (0.44) | ALDH1A1L3MBTL1MEN1KMT2AMAPT | |
| SCHEMBL7695168 | 0.83 | EGFR (0.50) | MEN1KMT2AMAPTRAB9ANPC1 | |
| SCHEMBL6689566 | 0.82 | DHODH (0.58) | ALDH1A1TDP1L3MBTL1LMNACYP3A4 | |
| SCHEMBL12172496 | 0.81 | DHODH (0.53) | ALDH1A1L3MBTL1TSHRATMDHODH | |
| SCHEMBL2040838 | 0.81 | TDP1 (0.55) | ALDH1A1TDP1L3MBTL1LMNACYP3A4 | |
| Hydrochloric Acid SCHEMBL14672810 | 0.80 | DHODH (0.56) | ALDH1A1TDP1LMNACYP3A4ALOX15 | |
| SCHEMBL14295958 | 0.79 | FLT3 (0.41) | CYP3A4TSHRDHODHKCNH3CDK1 | |
| SCHEMBL28464625 | 0.78 | TDP1 (0.45) | ALDH1A1TDP1L3MBTL1LMNACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | UDC IRELAND LIMITED (IE) | 2023-12-05 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2023-01-26 | — | — | US | disclosed |
| EP-3936512-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | Universal Display Corporation (US) | 2022-01-12 | — | — | EP | disclosed |
| EP-3424935-B1 | IMIDAZOPYRAZINYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORP (US) | 2021-08-11 | — | — | EP | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | UDC IRELAND LTD (IE) | 2021-04-29 | — | — | US | disclosed |
| US-20210050530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-18 | — | — | US | disclosed |
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-12-20 | — | — | US | disclosed |
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-12-20 | — | — | US | disclosed |
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-12-20 | — | — | US | disclosed |
| EP-2513125-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2012-10-24 | — | — | EP | disclosed |
| WO-2012121936-A2 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | WO | disclosed |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
| WO-2012121936-A2 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | UNIVERSAL DISPLAY CORPORATION (US) | 2012-09-13 | — | — | WO | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011073149-A1 | METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOL CARBENE-LIGANDS AND THE USE THEREOF IN OLEDS | BASF SE (DE) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120319050-A1 | METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OXA1L | ALDH1A1 2261/4885TDP1 4371/4885L3MBTL1 3381/4885 |
| US-20210050530-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | NUDC, NCL, NDC1 | ALDH1A1 3007/4885TDP1 2047/4885L3MBTL1 1096/4885 |
| US-20230026258-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885TDP1 4179/4885L3MBTL1 2835/4885 |
| US-11839140-B2 | Metal complexes comprising diazabenzmidazolocarbene ligands and the use thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885TDP1 4179/4885L3MBTL1 2835/4885 |
| US-20210126207-A1 | Metal Complexes Comprising Diazabenzmidazolocarbene Ligands and the Use Thereof in OLEDS | OCIAD1, OCIAD2, DRD2 | ALDH1A1 2588/4885TDP1 4179/4885L3MBTL1 2835/4885 |
| US-20120228583-A1 | PYRIDYL CARBENE PHOSPHORESCENT EMITTERS | PAICS, PIR, NUDC | ALDH1A1 3390/4885TDP1 1279/4885L3MBTL1 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.